Functional genomics: paving the way for more successful cancer immunotherapy

被引:6
|
作者
Ajina, Reham [1 ]
Zamalin, Danielle [2 ]
Weiner, Louis M. [3 ,4 ,5 ]
机构
[1] Georgetown Univ, Tumor Biol, Washington, DC 20057 USA
[2] Georgetown Univ, Washington, DC 20057 USA
[3] Georgetown Univ, Georgetown Lombardi Comprehens Canc Ctr LCCC, Washington, DC 20057 USA
[4] Dept Oncol, Washington, DC USA
[5] MedStar Georgetown Canc Inst, Washington, DC USA
关键词
cancer; functional genomics; immunotherapy; checkpoints; immunity; T-CELL-RECEPTOR; CLONAL EXPANSION; PD-L1; EXPRESSION; OPEN-LABEL; TUMOR; IPILIMUMAB; RESISTANCE; MECHANISMS; BLOCKADE; PEMBROLIZUMAB;
D O I
10.1093/bfgp/ely017
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Immunotherapies have revolutionized cancer treatment. Immunotherapy is effective for the treatment of a wide range of cancer types and can mediate complete and durable tumor regression. Nonetheless, the field still faces many significant challenges, such as the need for personalized therapeutic strategies and better biomarkers, the difficulty of selecting the right combination therapy, and resistance to currently available immunotherapies. Both cancer and host immunity comprise significantly diverse and complex ecosystems, making immunogenomics an ideal field for functional genomics analysis. In this review, we describe the cancer-immunity cycle, how cancer cells manage to evade immune attack and the current hurdles in the path of cancer immunotherapy. Then, we discuss how functional genomics approaches can pave the way for more successful cancer immunotherapies.
引用
收藏
页码:86 / 98
页数:13
相关论文
共 50 条
  • [41] Immunotherapy in non-small cell lung cancer: steps towards more effective combination therapies
    Rosenbaum, Matthew W.
    Mino-Kenudson, Mari
    TRANSLATIONAL CANCER RESEARCH, 2018, 7 : S774 - S778
  • [42] Cancer genome sequencing and functional genomics: from translational to clinical medicine
    Roukos, Dimitrios H.
    PHARMACOGENOMICS, 2011, 12 (10) : 1371 - 1374
  • [43] ROCK: a breast cancer functional genomics resource
    Sims, David
    Bursteinas, Borisas
    Gao, Qiong
    Jain, Ekta
    MacKay, Alan
    Mitsopoulos, Costas
    Zvelebil, Marketa
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 124 (02) : 567 - 572
  • [44] Functional Diversities of Regulatory T Cells in the Context of Cancer Immunotherapy
    Gao, Ran
    Shi, Guo-Ping
    Wang, Jing
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [45] Genomics meets immunity in pancreatic cancer: Current research and future directions for pancreatic adenocarcinoma immunotherapy
    Bowers, Jacob S.
    Bailey, Stefanie R.
    Rubinstein, Mark P.
    Paulos, Chrystal M.
    Camp, E. Ramsay
    ONCOLOGY REVIEWS, 2019, 13 (02): : 102 - 113
  • [46] Natural Killer Cells: The Linchpin for Successful Cancer Immunotherapy
    Shaver, Kari A.
    Croom-Perez, Tayler J.
    Copik, Alicja J.
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [47] Successful secondary radical operation on unretractable metastatic platinum-sensitive recurrent ovarian cancer by immunotherapy: a case report
    Sun, Li
    Li, Hua
    Wei, Sulan
    Yang, Meng
    Deng, Shaoqiong
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (12)
  • [48] Cancer Genomics Object Model: An Object Model for Multiple Functional Genomics Data for Cancer Research
    Park, Yu Rang
    Lee, Hye Won
    Cho, Sung Bum
    Kim, Ju Han
    MEDINFO 2007: PROCEEDINGS OF THE 12TH WORLD CONGRESS ON HEALTH (MEDICAL) INFORMATICS, PTS 1 AND 2: BUILDING SUSTAINABLE HEALTH SYSTEMS, 2007, 129 : 1235 - 1239
  • [49] ROCK: a breast cancer functional genomics resource
    David Sims
    Borisas Bursteinas
    Qiong Gao
    Ekta Jain
    Alan MacKay
    Costas Mitsopoulos
    Marketa Zvelebil
    Breast Cancer Research and Treatment, 2010, 124 : 567 - 572
  • [50] The future of cancer immunotherapy: DNA vaccines leading the way
    Aanshi Pandya
    Yesha Shah
    Nirjari Kothari
    Humzah Postwala
    Aayushi Shah
    Priyajeet Parekh
    Mehul R. Chorawala
    Medical Oncology, 40